CHRNA7 and non-small cell lung carcinoma: Furthermore, in 2009, Hildegard M. Schuller explained in detail that α7-nAChR agonists can induce NSCLC cells proliferation and angiogenesis and inhibit NSCLC apoptosis through multiple pathways [56].